DF4 Connector System Post-Approval Study

Sponsor
Medtronic (Industry)
Overall Status
Completed
CT.gov ID
NCT01638897
Collaborator
(none)
1,778
78
85.9
22.8
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate long-term performance of the DF4 Connector System. This evaluation is based on the number of DF4 lead-related complications occurring during the study compared to the number of leads enrolled in the study. The DF4 systems will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the DF4 Connector Systems. This study is conducted within Medtronic's post-market surveillance platform.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1778 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    DF4 Connector System Post-Approval Study
    Study Start Date :
    Jan 1, 2012
    Actual Primary Completion Date :
    Mar 1, 2019
    Actual Study Completion Date :
    Mar 1, 2019

    Outcome Measures

    Primary Outcome Measures

    1. DF4 Lead Related Complication Rate [Up to 5 Years]

      To demonstrate that the complication-free probability is greater than 92.5% at five years post-implant for the high voltage DF4 lead

    Secondary Outcome Measures

    1. Types of DF4 lead related events [Up to 5 years]

      Number of DF4 lead related events grouped by type

    2. Bipolar pacing impedance (ohms) [5 years]

      Summary statistics at 5 years post-implant will be reported.

    3. High voltage impedance (ohms) [5 years]

      Summary statistics at 5 years post-implant will be reported

    4. Pacing threshold (volts) [5 years]

      The pacing threshold is the minimum electrical stimulus needed to consistently depolarize the heart outside of the heart's refractory period. Summary statistics at 5 years post-implant will be reported.

    5. Sensing amplitude (millivolts) [5 years]

      The amplitude of the intrinsic cardiac electrical signals detected by electrodes on the defibrillator lead will be summarized at 5 years post-implant.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements

    • Subject is intended to be implanted or is within 30 days post-implant of a DF4 Connector System with a Medtronic DF4 lead used for a pacing, sensing and/or defibrillation application

    Exclusion Criteria:
    • Subject who is, or will be inaccessible for follow-up at a study site

    • Subject with exclusion criteria required by local law (Europe, Central Asia [ECA] only)

    • Implant and follow-up data, including any adverse device effects and system modifications at implant through the time of enrollment are unavailable

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Birmingham Alabama United States
    2 Anchorage Alaska United States
    3 Gilbert Arizona United States
    4 Scottsdale Arizona United States
    5 Jonesboro Arkansas United States
    6 Little Rock Arkansas United States
    7 Bakersfield California United States
    8 Chula Vista California United States
    9 Rancho Mirage California United States
    10 Salinas California United States
    11 San Diego California United States
    12 San Francisco California United States
    13 Torrance California United States
    14 Van Nuys California United States
    15 Colorado Springs Colorado United States
    16 Lakewood Colorado United States
    17 Newark Delaware United States
    18 Washington District of Columbia United States
    19 Bradenton Florida United States
    20 Clearwater Florida United States
    21 Albany Georgia United States
    22 Atlanta Georgia United States
    23 Marietta Georgia United States
    24 Indianapolis Indiana United States
    25 Des Moines Iowa United States
    26 Kansas City Kansas United States
    27 Edgewood Kentucky United States
    28 Louisville Kentucky United States
    29 Baton Rouge Louisiana United States
    30 Hyattsville Maryland United States
    31 Takoma Park Maryland United States
    32 Worcester Massachusetts United States
    33 Lansing Michigan United States
    34 Marquette Michigan United States
    35 Robbinsdale Minnesota United States
    36 Saint Louis Park Minnesota United States
    37 Saint Paul Minnesota United States
    38 Columbia Missouri United States
    39 Kansas City Missouri United States
    40 Saint Louis Missouri United States
    41 Henderson Nevada United States
    42 Morristown New Jersey United States
    43 Albuquerque New Mexico United States
    44 Garden City New York United States
    45 Huntington New York United States
    46 New York New York United States
    47 Poughkeepsie New York United States
    48 Utica New York United States
    49 Durham North Carolina United States
    50 Raleigh North Carolina United States
    51 Winston-Salem North Carolina United States
    52 Akron Ohio United States
    53 Cincinnati Ohio United States
    54 Cleveland Ohio United States
    55 Toledo Ohio United States
    56 Allentown Pennsylvania United States
    57 Erie Pennsylvania United States
    58 Lancaster Pennsylvania United States
    59 Philadelphia Pennsylvania United States
    60 Pittsburgh Pennsylvania United States
    61 Germantown Tennessee United States
    62 Kingsport Tennessee United States
    63 Nashville Tennessee United States
    64 Austin Texas United States
    65 Plano Texas United States
    66 The Woodlands Texas United States
    67 Burlington Vermont United States
    68 Olympia Washington United States
    69 Spokane Washington United States
    70 Tacoma Washington United States
    71 Madison Wisconsin United States
    72 Milwaukee Wisconsin United States
    73 Calgary Alberta Canada
    74 Kingston Ontario Canada
    75 Montreal Quebec Canada
    76 Quebec City Quebec Canada
    77 Trois-Rivieres Quebec Canada
    78 Nantes France

    Sponsors and Collaborators

    • Medtronic

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Medtronic
    ClinicalTrials.gov Identifier:
    NCT01638897
    Other Study ID Numbers:
    • DF4
    First Posted:
    Jul 12, 2012
    Last Update Posted:
    Mar 20, 2019
    Last Verified:
    Mar 1, 2019
    Keywords provided by Medtronic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 20, 2019